123 related articles for article (PubMed ID: 18368067)
21. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
23. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H
Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063
[TBL] [Abstract][Full Text] [Related]
24. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
26. Atypical Burkitt's lymphoma transforming from follicular lymphoma.
Hwang YY; Loong F; Chung LP; Chim CS
Diagn Pathol; 2011 Jul; 6():63. PubMed ID: 21736761
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
28. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
[TBL] [Abstract][Full Text] [Related]
29. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma.
Flinders C; Lam L; Rubbi L; Ferrari R; Fitz-Gibbon S; Chen PY; Thompson M; Christofk H; B Agus D; Ruderman D; Mallick P; Pellegrini M
Genome Med; 2016 May; 8(1):54. PubMed ID: 27146673
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
33. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
[TBL] [Abstract][Full Text] [Related]
34. Burkitt lymphoma and diffuse aggressive B-cell lymphoma.
Forteza-Vila J; Fraga M
Int J Surg Pathol; 2010 Jun; 18(3 Suppl):133S-135S. PubMed ID: 20484278
[No Abstract] [Full Text] [Related]
35. Cutaneous involvement with Burkitt-like lymphoma.
Pettey AA; Walsh JS
Am J Dermatopathol; 2007 Apr; 29(2):184-6. PubMed ID: 17414444
[TBL] [Abstract][Full Text] [Related]
36. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
37. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
[TBL] [Abstract][Full Text] [Related]
38. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
39. The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas.
Yang H; Chen CM; Yan P; Huang TH; Shi H; Burger M; Nimmrich I; Maier S; Berlin K; Caldwell CW
Clin Cancer Res; 2003 Sep; 9(11):4034-42. PubMed ID: 14519624
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin heavy chain variable gene utilization in human large cell and Burkitt's lymphoma cell lines.
Daley MD; Berinstein NL; Siminovitch KA
Clin Invest Med; 1994 Dec; 17(6):522-30. PubMed ID: 7895416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
